Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Barkin

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Scandinavian Journal of Urology and Nephrology|May 15, 2003
The Canadian Enuresis Study and Evaluation--short- and long-term safety and efficacy of an oral desmopressin preparationNorman M Wolfish, Jack Barkin, Fabian Gorodzinsky, et al.
The Canadian Journal of Urology|February 1, 1997
Measuring the minimum clinically important difference in BPH outcome measuresJohn E. Mahoney, William L. Orovan, Richard Casey, et al.
The Canadian Journal of Urology|November 19, 2017
The practical update for family physicians in the diagnosis and management of overactive bladder and lower urinary tract symptomsJack Barkin, Jeffrey Habert, Amy Wong, et al.
Expert Opinion on Pharmacotherapy|July 27, 2013
Tolterodine for the treatment of urge urinary incontinenceDean S Elterman, Bilal Chughtai, Steven A Kaplan, et al.
The Canadian Journal of Urology|July 1, 2014
A practical primary care approach to overactive bladderMatt T Rosenberg, Erik S Witt, Jack Barkin, et al.
The Journal of Urology|January 18, 2011
Efficacy of a second line luteinizing hormone-releasing hormone agonist after advanced prostate cancer biochemical recurrenceNathan Lawrentschuk, Kimberly Fernandes, David Bell, et al.
The Canadian Journal of Urology|July 1, 2014
A practical primary care approach to lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH-LUTS)Matt T Rosenberg, Erik S Witt, Martin Miner, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2008
Finasteride monotherapy maintains stable lower urinary tract symptoms in men with benign prostatic hyperplasia following cessation of alpha blockersJ Curtis Nickel, Jack Barkin, Caroline Koch, et al.
The Canadian Journal of Urology|February 27, 2020
Diagnosis of prostate cancer: the implications and proper utilization of PSA and its variants; indications and use of MRI and biomarkersKyle W Law, David-Dan Nguyen, Jack Barkin, et al.
The Canadian Journal of Urology|April 20, 2012
UroLift system for relief of prostate obstruction under local anesthesiaJack Barkin, Jonathan Giddens, Peter Incze, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Scandinavian Journal of Urology and Nephrology|May 15, 2003
The Canadian Enuresis Study and Evaluation--short- and long-term safety and efficacy of an oral desmopressin preparationNorman M Wolfish, Jack Barkin, Fabian Gorodzinsky, et al.
The Canadian Journal of Urology|February 1, 1997
Measuring the minimum clinically important difference in BPH outcome measuresJohn E. Mahoney, William L. Orovan, Richard Casey, et al.
The Canadian Journal of Urology|November 19, 2017
The practical update for family physicians in the diagnosis and management of overactive bladder and lower urinary tract symptomsJack Barkin, Jeffrey Habert, Amy Wong, et al.
Expert Opinion on Pharmacotherapy|July 27, 2013
Tolterodine for the treatment of urge urinary incontinenceDean S Elterman, Bilal Chughtai, Steven A Kaplan, et al.
The Canadian Journal of Urology|July 1, 2014
A practical primary care approach to overactive bladderMatt T Rosenberg, Erik S Witt, Jack Barkin, et al.
The Journal of Urology|January 18, 2011
Efficacy of a second line luteinizing hormone-releasing hormone agonist after advanced prostate cancer biochemical recurrenceNathan Lawrentschuk, Kimberly Fernandes, David Bell, et al.
The Canadian Journal of Urology|July 1, 2014
A practical primary care approach to lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH-LUTS)Matt T Rosenberg, Erik S Witt, Martin Miner, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2008
Finasteride monotherapy maintains stable lower urinary tract symptoms in men with benign prostatic hyperplasia following cessation of alpha blockersJ Curtis Nickel, Jack Barkin, Caroline Koch, et al.
The Canadian Journal of Urology|February 27, 2020
Diagnosis of prostate cancer: the implications and proper utilization of PSA and its variants; indications and use of MRI and biomarkersKyle W Law, David-Dan Nguyen, Jack Barkin, et al.
The Canadian Journal of Urology|April 20, 2012
UroLift system for relief of prostate obstruction under local anesthesiaJack Barkin, Jonathan Giddens, Peter Incze, et al.
Pageof 11